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1684-1182/Copyright ª 2014, TaiwanBackground: Staphylococcus aureus is a leading cause of nosocomial infections. The purpose of
this study was to evaluate the prevalence of methicillin-resistant S. aureus (MRSA) and hetero-
geneous vancomycin-intermediate S. aureus (hVISA), and compare the antimicrobial suscepti-
bility, molecular characteristic, and virulence factors in methicillin-susceptible S. aureus
(MSSA), MRSA, and hVISA from central-southern China.
Methods: A total of 184 S. aureus were isolated from sterile body fluids. All isolates were sub-
jected to population analysis profiling for the identification of hVISA phenotype and polymer-
ase chain reaction analysis for genotyping and 31 virulence genes.
Results: The prevalence of MRSA isolates was 41.8% in central-southern China. Of 77 MRSA iso-
lates, 17 (22.1%) were identified as hVISA. The most common MRSA and MSSA clones weret of Laboratory, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Tech-
(ZY. Sun).
.03.003
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Staphylococcus aureus genotyping and virulence factor 491Staphylococcus
aureus;
Virulence geneST239-MRSA-SCCmecIII-t030-agr-I (55.8%) and ST188-MSSA-t189-agr-I (20.6%), respectively. The
frequency of carriage of pvl, hemolysins, tst, and staphylococcal enterotoxin genes among
MSSA isolates was significantly higher than that for MRSA isolates (p < 0.05); 98 MSSA isolates
(53.3%) carried 10 tested virulence genes simultaneously, which was significantly higher than
that of MRSA isolates (33.8%; p Z 0.004). The 17 hVISA isolates carried a significantly small
number of virulence genes; only two hVISA isolates carried 10 tested virulence genes simul-
taneously, and two hVISA isolates harbored only four virulence genes. Compared with other
clonal complexes (CCs), CC1 and CC398 isolates harbored a higher frequency of exfoliatin
genes, CC1 and CC59 harbored a higher frequency of pvl gene, and only CC1 isolates harbored
lukED.
Conclusion: The prevalence of hVISA was considerably high in central-southern China. Simulta-
neous carriage of multiple virulence genes was common in S. aureus isolates; the virulence
genes were more diverse and frequent among MSSA isolates than among MRSA isolates.
Furthermore, the distribution of some virulence genes was correlated with the different S.
aureus CCs.
Copyright ª 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Since Alexander Ogston first isolated Staphylococcus aureus
from a surgical abscess in 1880 and described its role in
localized infection and septicemia,1,2 S. aureus has been
recognized as an important cause of human disease for
nearly 130 years. The pathogenesis of S. aureus infections is
related to the expression of a wide variety of virulence
factors, including coagulase, hemolysins (which damage cell
membrane of various cells), staphylococcal enterotoxins
(SEs; which cause food poisoning), toxic shock syndrome
toxin-1 (TSST-1; which increases sensitivity to endotoxin),
exfoliative toxins (which are implicated in staphylococcal
scalded-skin syndrome), staphylococcal protein A (spa), and
PantoneValentine leukocidin (pvl, which has been prefer-
entially linked to furuncles, cutaneous abscesses, and se-
vere necrotic skin infections).3e5 Generally, serious S.
aureus infections are caused by the combined actions of
several virulence factors; S. aureus strains causing in-
fections have variable combinations of virulence genes.6,7
Since its emergence in the 1980s, methicillin-resistant S.
aureus (MRSA) has become a major cause of nosocomial
infections worldwide. Vancomycin, a glycopeptide antibi-
otic introduced 50 years ago, is regarded as the mainstay of
treatment for MRSA infections. Since first reported in Japan
in 1997,8 heterogeneous vancomycin-intermediate S.
aureus (hVISA) have been detected throughout the world,
which has threatened the rank of vancomycin as the first-
line antibiotic for MRSA infections. The clinical signifi-
cance of hVISA has been difficult to assess. It is unknown
whether these isolates are fully virulent or just more viru-
lent than vancomycin-susceptible S. aureus isolates and
whether their levels of resistance are responsible for
treatment failure.9 The prevalence of hVISA varied signifi-
cantly, which can be attributed to many factors, including
differences in laboratory definitions, testing strategies, and
regional variability.10,11
The prevalence of hVISA among MRSA isolates from China
in 2007 was 15.7%12; however, the hVISA phenotype was
determined by a combination of the following factors: (1)measurement by the modified population analysis profile/
area under the curve method (PAP/AUC) and (2) estimation
based on the measured sensitivity and specificity of a
screening method, which was somewhat limited. The aim of
this study was to investigate the prevalence of hVISA and
compare the antimicrobial susceptibility, molecular char-
acteristics, and virulence-associated gene carriage in
methicillin-susceptible, resistant, and heterogeneous
vancomycin-intermediate S. aureus from six tertiary




A total of 184 consecutive and nonduplicated S. aureus
isolates were collected from six tertiary teaching hospitals
in central-southern China, from June 2011 to May 2012. The
hospitals included Tongji Hospital, Tongji Medical College,
Huazhong University of Science and Technology (57 iso-
lates), the First Affiliated Hospital of Zhengzhou University
(45 isolates), Xiangya Hospital of Central South University
(39 isolates), the Second Xiangya Hospital of Central South
University (24 isolates), Henan Province People’s Hospital
(12 isolates), and Union Hospital, Tongji Medical College,
Huazhong University of Science and Technology (7 isolates).
The strains were isolated from blood (141 isolates), cere-
brospinal fluid (15 isolates), ascites (11 isolates), pleural
effusion (10 isolates), and synovial fluid (7 isolates). All
isolates were stored at 80C until testing.
Antimicrobial susceptibility testing
Identification of S. aureus isolates was performed using
standard methods and the Vitek 2 compact automated
system (bioMe´rieux, Marcy-l’E´toile, France). Minimum
inhibitory concentrations of antibiotics were determined
using the agar dilution method, according to the Clinical
492 C. Liu et al.and Laboratory Standards Institute recommendations. The
reference strain ATCC 29213 was used as a control.
Modified PAP/AUC
PAP/AUC was performed as described by Wootton et al.13
Following 24 hours of incubation in Tryptone Soya Broth
(Oxoid, Basingstoke, England), neat culture and dilutions of
103 (105 CFU/mL) and 106 (102 CFU/mL) were plated onto
Brain Heart Infusion agar (Oxoid) plates containing 0.0 mg/
L, 0.5 mg/L, 1.0 mg/L, 2.0 mg/L, 2.5 mg/L, 4.0 mg/L, and
8.0 mg/L vancomycin. Colonies were counted after 48
hours. Control strains [ATCC 29213 (methicillin-susceptible
S. aureus, MSSA), Mu50, and Mu3] were included in each
run. Calculated CFU/mL values were plotted against van-
comycin concentration using Prism version 5.0 (GraphPad
Software, San Diego, CA, USA). The ratio of the AUC of the
test isolate to the AUC of Mu3 was calculated and inter-
preted as follows: for VSSA, a ratio of <0.9; for hVISA, a
ratio of 0.9e1.3; and for VISA, a ratio of 1.3.
DNA isolation
All isolates were cultured on blood agar and incubated
overnight at 37C. Genomic DNA was extracted using the
Puregene Yeast/Bact. Kit (Qiagen, Valencia, CA, USA) ac-
cording to the manufacturer’s protocol for Gram-positive
bacteria. DNA samples were stored at 20C until used.
Detection of virulence genes
The pvl gene was detected by amplification of the lukS-PV
and lukF-PV genes, as described by Lina et al.14 S. aureus
ATCC 49775, harboring pvl gene, was used as a control strain.
The presence of the virulence gene-encoded hemolysins (hla,
hlb, hld, hlg, and hlg variant), leukotoxins (lukED and lukM ),
exfoliatins (eta, etb, and etd ), edin, toxic shock syndromeTable 1 Antimicrobial resistance rates of 184 Staphylococcus a
Antimicrobial agents MSSA (n Z 107) MRSA (n Z















a Chi-square test or Fisher’s exact test.
hVISAZ heterogeneous vancomycin-intermediate S. aureus; MRSAZ
aureus.toxin (tst), and SEs (sea, seb, sec, sed, see, seg, seh, sei, sej,
sek, sel, sem, sen, seo, sep, seq, ser, and seu) were investi-
gated by multiplex polymerase chain reaction (PCR).6,15
Molecular typing
Multiplex PCR was used to amplify the mecA gene and
determine the SCCmec type (IeV) of all MRSA isolates, ac-
cording to the method published by Milheirico et al.16
Multilocus sequence typing was examined following a pre-
viously described method.17 The accessory gene regulator
(agr) polymorphism was determined by multiplex PCR using
a previously described method.18 According to the method
described by Harmsen et al,19 spa typing was performed,
and spa types with identical or similar repeat profiles were
grouped into clusters (http://www.ridom.de/spaserver).
Statistical analysis
Chi-square test or Fisher’s exact test for categorical vari-
ables were used to calculate p values. A p value <0.05 was
considered statistically significant. All susceptibility data




The prevalence of MRSA isolates was 41.8% (77/184) in
central-southern China. A total of 17 hVISA strains were
identified by modified PAP/AUC; the percentage of hVISA
among MRSA isolates was 22.1% (17/77). The antimicrobial
resistance profiles for 184 S. aureus isolates are listed
in Table 1. All isolates were susceptible to vancomycin,
teicoplanin, linezolid, daptomycin, and tigecycline. Signif-
icant differences were observed in antimicrobial resistanceureus isolates
77) pa Non-hVISA (n Z 60) hVISA (n Z 17) pa
R (%) R (%)
<0.001 75.0 100 0.032
<0.001 75.0 100 0.032
<0.001 86.7 100 0.018
<0.001 86.7 100 0.018
<0.001 70.0 88.2 0.210
0.148 10.0 29.4 0.058
<0.001 58.3 100 0.001
<0.001 81.7 94.1 0.282
0.244 3.3 29.4 0.005
d 0 0 d
d 0 0 d
d 0 0 d
d 0 0 d
d 0 0 d
methicillin-resistant S. aureus; MSSAZ methicillin-susceptible S.
Staphylococcus aureus genotyping and virulence factor 493to gentamicin, levofloxacin, tobramycin, erythromycin,
clindamycin, tetracycline, and rifampin between MRSA and
MSSA isolates (p < 0.05). Among MRSA isolates, hVISA iso-
lates had significantly higher resistance to gentamicin,
levofloxacin, tobramycin, erythromycin, tetracycline, and
trimethoprim/sulfamethoxazole than non-hVISA isolates
(p < 0.05).
Prevalence of virulence genes among S. aureus
Of 184 S. aureus isolates, the most frequent toxin genes
were hemolysin genes (except hlg); all isolates exhibited
carriage of at least two hemolysin genes, followed by lukED
(91.3%), seg (42.4%), sei (32.6%), and seq (31.5%) (Table 2).
The frequency of carriage of pvl, tst, hlb, hlg-v, seb,
sed, and sei among MSSA isolates was significantly higher
than that of MRSA isolates (p < 0.05). A total of 98 MSSA
isolates (53.3%) carried 10 tested virulence genes simul-
taneously, which was significantly higher than that of MRSA
isolates (33.8%, 26/77; p Z 0.004).Table 2 Prevalence of 31 virulence genes among Staphylococcu
Virulence genes S. aureus (n Z 184)
(%)
MSSA (n Z 107) MRSA (n
(%) (%)
hla 96.7 99.1 93.5
hlb 88.0 91.6 77.9
hld 96.7 99.1 93.5
hlg 11.4 13.1 9.1
hlg-v 88.6 95.3 79.2
lukED 91.3 93.5 88.3
lukM 2.2 3.7 0.0
eta 6.5 5.6 7.8
etb 14.1 16.8 10.4
etd 4.9 3.7 6.5
sea 26.1 28.0 23.4
seb 25.0 33.6 13.0
sec 6.0 4.7 7.8
sed 6.0 9.3 1.3
see 4.9 6.5 2.6
seg 42.4 44.9 39.0
seh 7.1 7.5 6.5
sei 32.6 39.3 23.4
sej 8.7 9.3 7.8
sek 27.2 16.8 41.6
sel 8.7 11.2 5.2
sem 7.6 5.6 10.4
sen 6.5 4.7 9.1
seo 5.4 4.7 6.5
sep 1.1 1.9 0.0
seq 31.5 19.6 48.1
ser 6.5 8.4 3.9
seu 14.1 18.7 7.8
edin 6.0 7.5 3.9
pvl 10.3 16.8 1.3
tst 7.6 11.2 2.6
a The prevalence of virulence genes among MRSA were compared w
b The prevalence of virulence genes among non-hVISA MRSA were c
hVISAZ heterogeneous vancomycin-intermediate S. aureus; MRSAZ
aureus.Among MRSA isolates, the frequency of carriage of hlb,
hld, and seg in non-hVISA isolates was significantly higher
than that of hVISA isolates (p < 0.05). Comparing with MSSA
isolates and non-hVISA isolates, hVISA isolates carried a
significantly small number of virulence genes; only two
hVISA isolates carried 10 tested virulence genes simulta-
neously, and two hVISA isolates harbored only four viru-
lence genes.
Molecular characteristics of S. aureus
A total of 21 STs and 39 spa types were identified in 184 S.
aureus isolates. Clustering analysis by eBURST showed that
these STs belonged to 13 clonal complexes (CCs; Table 3).
The predominant types among MRSA isolates were CC8
(71.4%, 55/77), t030 (55.8%, 43/77), and SCCmec type III
(85.7%, 64/77). However, the predominant types in the MSSA
group were CC1 (33.6%, 36/107) and t189 (20.6%, 22/107).
Overall, ST239-MRSA-SCCmecIII-t030-agr-I was the most
common clone (55.8%, 43/77) among MRSA isolates. Amongs aureus strains isolated from sterile body fluids
Z 77) pa Non-hVISA (n Z 60) hVISA (n Z 17) pb
(%) (%)
0.084 96.7 82.4 0.068
0.010 85.0 52.9 0.009
0.084 98.3 76.5 0.008
0.485 8.3 11.8 1.000
0.001 75.0 88.2 0.332
0.290 91.7 76.5 0.102
0.141 0.0 0.0 d
0.540 6.7 11.8 0.608
0.284 11.7 5.9 0.676
0.494 6.7 5.9 1.000
0.501 23.3 23.5 1.000
0.002 15.0 5.9 0.443
0.530 5.0 17.6 0.118
0.027 1.7 0 1.000
0.308 3.3 0.0 1.000
0.648 46.7 11.8 0.011
1.000 5.0 11.8 0.580
0.026 21.7 29.4 0.526
0.795 5.0 17.6 0.118
<0.001 40.0 47.1 0.781
0.190 5.0 5.9 1.000
0.266 11.7 5.9 0.676
0.365 6.7 17.6 0.337
0.744 6.7 5.9 1.000
0.511 0.0 0.0 d
<0.001 40.0 76.5 0.012
0.247 5.0 0.0 0.589
0.052 10.0 0 0.329
0.364 3.3 0.0 1.000
0.001 1.7 0.0 1.000
0.045 3.3 0.0 1.000
ith those among MSSA isolates.
ompared with those among hVISA MRSA isolates.
methicillin-resistant S. aureus; MSSAZ methicillin-susceptible S.
Table 3 Molecular characteristics of 184 Staphylococcus aureus isolates




spa type (no.) SCCmec type (no.) agr type (no.) Virulence genes (%)
8 (55) 239 (50) 50 0 t030 (43), t037 (4),
t437 (2), t2207 (1),
III (49), NT (1) I (50) hla (94.5), hlb (81.8), hld (94.5), hlg (9.1), hlg-v (80.0), lukED (90.9),
eta (7.3), etb (9.1), etd (5.5), sea (18.2), seb (5.5), sec (9.1), seg (38.2),
seh (5.5), sei (27.3), sej (10.9), sek (47.3), sem (10.9), sen (9.1),
seq (52.6), seu (7.3), pvl (1.8), tst (3.6)
432 (3) 3 0 t2207 (3) III (3) I (3)
250 (1) 1 0 t2526 (1) NT (1) I (1)
630 (1) 1 0 t441 (1) III (1) I (1)
1 (37) 188 (31) 1 30 t189 (23), t127 (6),
t030 (2)
IV (1) I (25), III (3),
II (3)
hla (100), hlb (97.3), hld (100), hlg (27.0), hlg-v (100), lukED (100),
lukM (10.8), eta (8.1), etb (24.3), etd (5.4), sea (48.6), seb (48.6),
sec (10.8), seg (48.6), seh (21.6), sei (48.6), sej (21.6), sek (27.0),
seq (40.5), ser (16.2), seu (27.0), edin (21.6), pvl (32.4), tst (27.0)
1 (6) 0 6 t127 (4), t114 (1),
t7117 (1)
NA III (3), II (3)
398 (16) 398 (16) 1 15 t571 (6), t011 (6),
t034 (3), t1451 (1)
II (1) I (12), II (3),
NT (1)
hla (100), hlb (100), hld (100), hlg (18.8), hlg-v (100), lukED (100),
eta (12.5), etb (31.2), etd (12.5), sea (37.5), seb (50.0), see (18.8),
seg (50.0), sei (50.0), sej (12.5), sek (25.0), sel (50.0), sem (18.8),
seq (18.8), pvl (12.5)
59 (13) 59 (13) 3 10 t437 (10),
t5350 (2), t163 (1)
IV (3) I (8), II (5) hla (92.3), hlb (100), hld (100), hlg (7.7), hlg-v (100), lukED (100),
sea (15.4), seb (30.8), sec (38.5), sed (30.8), see (15.4), seg (46.2),
sei (46.2), sek (30.8), sen (38.5), seo (38.5), seq (7.7), ser (23.1),
seu (30.8), pvl (30.8), tst (15.4)
7 (12) 7 (12) 0 12 t796 (5), t091 (5),
t189 (2)
NA I (12) hla (100), hlb (83.3), hld (100), hlg-v (100), lukED (100), eta (8.3),
sea (33.3), seb (33.3), sed (16.7), seg (66.7), sei (66.7), sel (33.3),
sem (16.7), sep (16.7), seq (16.7), seu (41.7)
30 (11) 36 (9) 9 0 t233 (9) III (7), II (2) I (9) hla (90.9), hlb (81.8), hld (100), hlg (9.1), hlg-v (81.8), lukED (81.8),
eta (9.1), sea (27.3), seb (27.3), seg (54.5), sei (18.2), sek (45.5),
sel (9.1), seo (18.2), seq (45.5), edin (27.3)
910 (1) 0 1 t318 (1) NA IV (1)
30 (1) 0 1 t338 (1) NA III (1)
5 (9) 5 (7) 5 2 t002 (4), t1376 (1),
t045 (1), t548 (1)
III (4), NT (1) I (6), IV (1) NC
1920 (1) 1 0 t286 (1) III (1) I (1)
965 (1) 0 1 t062 (1) NA NT I (1)
25 (9) 25 (9) 1 8 t078 (8), t081 (1) III (1) I (8), IV (1) NC
121 (8) 121 (6) 0 6 t2091 (6) NA II (4), IV (2) NC
1301 (2) 1 1 t2019 (1), t6662 (1) II (1) IV (2) NC
6 (5) 6 (5) 0 5 t701 (5) NA I (5) NC
88 (4) 88 (4) 0 4 t1950 (1), t6979 (1),
t5269 (1), t377 (1)
NA II (3), III (1) NC
20 (3) 20 (3) 0 3 t164 (2), t1089 (1) NA I (3) NC
15 (2) 15 (2) 0 2 t084 (2) NA I (2) NC
CC Z clonal complex; hVISA Z heterogeneous vancomycin-intermediate S. aureus; MLST Z multilocus sequence typing; MRSA Z methicillin-resistant S. aureus; MSSA Z methicillin-









Staphylococcus aureus genotyping and virulence factor 495MSSA isolates, the predominant clone was ST188-MSSA-
t189-agr-I (20.6%, 22/107). The 17 hVISA isolates were iso-
lated from blood (12 isolates), cerebrospinal fluid (2 iso-
lates), ascites (2 isolates), and pleural effusion (1 isolate).
ST239-SCCmecIII-t030-agr-I was the most common clone (15
isolates); other clones identified included ST5-SCCmecIII-
t002-agr-II and ST1301-SCCmecII-t2019-agr-IV (1 isolate
each).
The distribution of virulence genes in major CCs is shown
in Table 3. Among 55 CC8 isolates, the most prevalent SE
genes were seq (52.6%), sek (47.3%), seg (38.2%), and sei
(27.3%). Among CC1 isolates were sea (48.6%), seb (48.6%),
seg (48.6%), and sei (48.6%), and among CC398 isolates, seb
(50.0%), sej (50.0%), sei (50.0%), and sea (37.5%). Compared
with other CC isolates, CC1 and CC398 isolates harbored a
higher frequency of exfoliatin genes, CC1 and CC59
harbored a higher frequency of pvl gene, and only CC1
isolates harbored lukED gene.Discussion
In the present study, 184 S. aureus isolates obtained from
six tertiary teaching hospitals in central-southern China
were surveyed. The prevalence of MRSA isolates was
41.8%. The strains were isolated from sterile body fluids,
mainly from blood (141 isolates); the prevalence of MRSA
among S. aureus blood stream infection (BSI) was 40.4%
(57/141). S. aureus is the leading cause of BSI in many
countries.20e22 A previous study reported that 41.6% of S.
aureus BSI isolates from Zhejiang province were MRSA.23
Our study further indicates that MRSA is an important
etiologic agent of severe, life-threatening infections in
China and suggests the need for active surveillance to
identify patients at risk. A total of 17 hVISA isolates were
identified by modified PAP/AUC; the prevalence of hVISA
among MRSA isolates was 22.1%. The highest hVISA preva-
lence rate among MRSA isolates in Asia was 15.7% in
China,12 followed by 12.5% in Singapore;24 our results
showed a higher prevalence. To our knowledge, it was the
highest rate of hVISA in China.
Our results showed that MRSA isolates exhibited low
resistance to chloramphenicol (14.3%) and trimethoprim/
sulfamethoxazole (9.1%). This supports the potential utility
of chloramphenicol and trimethoprim/sulfamethoxazole as
empiric treatment agents for S. aureus in China. Among
MRSA isolates, hVISA had significantly higher resistance to
gentamicin, levofloxacin, tobramycin, erythromycin,
tetracycline, and trimethoprim/sulfamethoxazole than
non-hVISA isolates, which indicated that antimicrobial op-
tions for hVISA are very limited. This finding is similar to
that of a previous study, which showed that hVISA isolates
had higher resistance to ciprofloxacin, gentamicin,
trimethoprim/sulfamethoxazole, and tetracycline.25
The clinical outcome of S. aureus infections is influenced
by antimicrobial resistance and virulence factors. This is
believed to be the first study to report the presence of 31
virulence genes in MSSA, MRSA, and hVISA from China. The
results showed that MSSA harbored a higher frequency of
virulence genes than MRSA; 98 MSSA isolates (53.3%) carried
10 tested virulence genes simultaneously, which was
significantly higher than that of MRSA isolates (33.8%;pZ 0.004). A total of 24 non-hVISA isolates (40.0%) carried
10 tested virulence genes simultaneously, which was
significantly higher than that of hVISA isolates (11.8%;
pZ 0.041); two hVISA isolates harbored only four virulence
genes. This result was different from a previous report,
which showed that MRSA isolates harbored more super-
antigen and pvl genes than MSSA isolates.23 It has been
reported that the acquisition of antibiotic resistance in S.
aureus involves changes in virulence factor secretion due to
the fitness cost associated with the expression of resis-
tance, and it is reflected in decreased toxin
expression.26e28 Therefore, it is reasonable that the results
of our study confirmed this by showing that virulence factor
gene carriage was more diverse and abundant in MSSA than
in MRSA strains.
In this study,184 S. aureus isolates belonged to 13 CCs:
CC8 (29.9%), CC1 (20.1%), CC398 (8.7%), CC59 (7.1%), CC7
(6.5%), CC30 (6.0%), CC5 (4.9%), CC25 (4.9%), CC121 (4.3%),
CC6 (2.7%), CC88 (4 isolates), CC20 (3 isolates), and CC15 (2
isolates). Distribution of some virulence genes was corre-
lated with the different S. aureus lineages.29 Compared
with other CC isolates, CC1 and CC398 isolates harbored a
higher frequency of exfoliatin genes, CC1 and CC59
harbored a higher frequency of pvl gene, and only CC1
isolates harbored lukED, indicating that different CCs had
different virulence profiles.
SCCmec, multilocus sequence, agr, and spa typing were
performed in this study; our results revealed that molecular
characteristics were significantly different between MRSA
and MSSA. ST239-MRSA-SCCmecIII and ST5-MRSA-SCCmecII
were identified as major epidemic clones among MRSA
isolates in China.30,31 In this study, ST239-MRSA-SCCmecIII-
t030-agr-I was the most common MRSA clone (55.8%).
Among 17 hVISA isolates, ST239-MRSA-SCCmecIII-t030-agr-I
was the predominant clone (15 isolates); a similar finding
was noted previously.12 Among MSSA isolates, the dominant
clone was ST188-MSSA-t189-agr-I (20.6%).
In conclusion, this study showed the prevalence of MRSA
isolates collected from sterile body fluids was 41.8% in
central-southern China; the prevalence of hVISA in MRSA
isolates was considerably high, up to 22.1%. The predomi-
nant MRSA, hVISA, and MSSA clones were ST239-SCCmecIII-
t030-agr-I and ST188-MSSA-t189-agr-I, respectively.
Furthermore, we found that the frequency of carriage of
pvl, hemolysins, tst, and SE genes among MSSA isolates was
significantly higher than that among MRSA isolates; viru-
lence genes were more diverse and frequent in MSSA iso-
lates than those in MRSA isolates, and the distribution of
some virulence genes was correlated with the different S.
aureus CCs.Conflicts of interest
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